| 1 |
Fogagnolo et al
16
|
Brazil |
2 |
Thalidomide 300mg/day, Prednisolone 80mg/day |
0 |
No-Not always mandatory |
| 2 |
Rahul nagar
17
|
India |
3 |
I- Prednisolone 40 mg/day |
1 |
Yes |
|
|
|
|
|
clofazimine 300 mgs/day |
|
|
|
|
|
|
|
thalidomide was tapered below 100 mgs/day. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
II- Prednisolone 40 mgs/day,clofazimine 100 mgs three times a day prednisolone in higher doses of 60 mgs/day. Two successive thalidomide courses were also found |
1 |
|
|
|
|
|
|
III- Prednisolone 40 mgs/day,clofazimine 100 mgs three times a day prednisolone in higher doses of 60 mgs/day. Two successive thalidomide courses were also found |
1 |
|
| 3 |
Rattan et al
18
|
India |
4 |
Thalidomide 100mg/thrice a day + MDT - MB |
0 |
No |
|
|
|
|
|
Thalidomide 100mg/thrice a day + MDT - MB Thalidomide 100mg/thrice a day + MDT - MB |
|
|
|
|
|
|
|
Thalidomide 100mg/thrice a day + MDT - MB |
|
|
| 4 |
Mahajan et al
21
|
India |
1 |
Treatment restarted with prednisone (60 mg/day), clofazimine (100 mg three times/day), rifampicin (600 mg once a month), thalidomide (100 mg three times/day) |
1 |
Yes |
| 5 |
Jitendra ssv et al
22
|
India |
1 |
Prednisolone 1 mg/kg/day |
1 |
Yes |
|
|
|
|
|
Clofazimine 300 mg/day for six months and 100 mg/day for another six months |
|
|
|
|
|
|
|
Thalidomide 200 mg/day (STOPPED) |
|
|
| 6 |
T . Narang et al
23
|
India |
1 |
Started rationale dose but patient not tolerated (apremilast) |
1 |
Yes |
| 7 |
Barman et al
24
|
India |
1 |
MDT, Thalidomide - 100mg, T. Prednisolone. |
0 |
No |
| 8 |
Richards
25
|
Pt from Micronesia- treated at Dallas, Texas |
1 |
MDT, Prednisolone 60mg/day, Thalidomide - 100mg |
0 |
No, Not always mandatory |
| 9 |
Rodriguez
26
|
Colombia |
1 |
MDT, Thalidomide 300mg/day, Prednisolone 50mg/day |
0 |
No, Not always mandatory |
| 10 |
Verma et al
27
|
India |
1 |
MDT, Prednisolone 40mg/day, Thalidomide 100mg TDS, Azathiprine 50mg/twice daily. |
0 |
No |
| 11 |
Verma et al
27
|
India |
1 |
MDT,Prednisolone 1mg/kg/day, Thallidomide 100mg QID for 4 months |
0 |
No |
| 12 |
Yogeesh HR et al
28
|
India |
1 |
MDT, Prednisolone 30mg, Thalidomide 100mg TDS, |
0 |
No |
| 13 |
Faber et al
29
|
Netherlands |
1 |
MDT, Steroids, Thalidomide 300mg, Pentoxiphylline 400mg, Finally, Infliximab 5mg/kg. |
0 |
No, Not always mandatory |
| 14 |
Hebe Petiti-Martin et al
30
|
Spain |
1 |
MDT, Prednisolone, Thalidomide - 150mg/day [stopped], Enoxeparin, Acenocoumoral |
0 |
No, Not always mandatory |
| 15 |
Vetrichevel et al
31
|
India |
1 |
MDT, Corticosteroids, Thalidomide 300mg/day then stopped, LMWheparin, Warfarin for 6 months. |
0 |
No |
| 16 |
Sundeep chowdary et al
32
|
India |
1 |
Prednisolone (40-80 mg) |
1 |
No |
|
|
|
|
|
Etanercept (50 mg / week) subcutaneously. |
|
|
|
|
|
|
|
Clofazimine (300 mg daily), |
|
|
|
|
|
|
|
Thalidomide (starting dose: 300 mg daily), |
|
|
|
|
|
|
|
Minocycline (100 mg daily), |
|
|
|
|
|
|
|
Clarithromycin (1 g daily), |
|
|
|
|
|
|
|
Ofloxacin (400 mg daily), |
|
|
|
|
|
|
|
Pentoxifylline (400 mg three times daily), |
|
|
|
|
|
|
|
Azathioprine (150 mg daily; later increased to 300 mg) |
|
|
| 17 |
Julia Rocha Silva Santos et al
33
|
Brazi |
1 |
Thalidomide (100- 300 mg/day) |
0 |
No, Not always mandatory |
|
|
|
l |
|
prednisone at (20 - 40mg/day) |
|
|
|
|
|
|
|
50mg of etanercept SC. |
|
|
|
|
|
|
|
Thalidomide was interrupted |
|
|
|
|
|
|
|
Prednisone was continued at a dose of 10mg/day |
|
|
| 18 |
Gulanikar et al
34
|
India |
1 |
Prednisolone 30mg . Thalidomide 100mg QID |
0 |
No |
| 19 |
Yamaghuchi et al
35
|
Japan |
1 |
PSL 15-55 mg⁄ day,Thalidomide 100-300 mg⁄ day |
0 |
No, Not always mandatory |
| 20 |
Sharma et al
36
|
India |
1 |
MDT |
0 |
No |
|
|
|
|
|
Prednisolone 60 mg/d, |
|
|
|
|
|
|
|
Ibuprofen 400 mg t.i.d. |
|
|
|
|
|
|
|
colchicine 0.5 mg b.i.d. |
|
|
|
|
|
|
|
thalidomide 100mg bd and stopped
|
|
|
| Rationale with respect to use of thalidomide in planned dose: |
| 21 |
Satyendra Kumar Singh et al
37
|
|
|
Plan for Thalidomide in desired rationale dose |
|
|
| 22 |
Prasan Kumar Panda et al
38
|
|
|
Plan for Thalidomide in desired rationale dose |
|
|